During the past decade, Adana City Hospital conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 3 clinical trials were completed, i.e. on average, 13.6% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 3 clinical trials were completed. i.e. 15.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Adana City Hospital" #1 sponsor was "Janssen Research & Development, LLC" with 6 trials, followed by "Adana City Training and Research Hospital" with 3 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Adana Numune Training and Research Hospital" with 2 trials sponsored and "Eli Lilly and Company" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Adana City Hospital" #1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Adana City Hospital" are "Carcinoma, Non-Small-Cell Lung" (4 trials), "Neoplasms" (3 trials), "Non Small Cell Lung Cancer" (2 trials), "Adenocarcinoma" (1 trials) and "Advanced or Metastatic Non-small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Adana City Hospital" in a lesser frequency.

Most popular intervention types in "Adana City Hospital" are "Drug" (15 trials), "Other" (2 trials), "Diagnostic Test" (1 trials), "Genetic" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (5 trials), "Pemetrexed" (5 trials), "Placebo" (5 trials), "Amivantamab" (3 trials) and "Lazertinib" (3 trials). Other intervention names were less common.

The vast majority of trials in "Adana City Hospital" are 19 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Adana City Hospital". undefined are not yet recruiting, 9 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Adana City Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Adana City Hospital, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".